Cryselle Kit
Product Images NDC 0480-3493
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cryselle (NDC 0480-3493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
2 (Cryselle Image 2)
1 (Cryselle Image 3)
This text provides information on the comparison of contraceptive pill (COC) usage and its impact based on various studies. It includes data such as odds ratios (OR), risk ratios (RR), and hazard ratios (HR) from studies like NICHD Women's Care Study, French E3N cohort Study, Shanghai Women’s Health Study, The Nurses' Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The text also presents a range of effect estimates for each comparison. This data can be used to evaluate the potential associations between COC usage and various health outcomes.*
1 (Cryselle Image 4)
This text provides information on different methods of birth control, such as implants, injections, intrauterine devices, sterilization, birth control pills, condoms, diaphragm, and other options. It also mentions the varying rates of pregnancies per 100 women in one year depending on the method chosen, from fewer than 1 pregnancy to 10-20 pregnancies to 85 or more pregnancies. Additionally, it lists methods like using no birth control, having no sex during the most fertile days of the monthly cycle, spermicide, withdrawal, skin patch, and vaginal ring with hormones.*
2 (Cryselle Image 5)
3 (Cryselle Image 6)
1 (Cryselle Image 7)
The text is a detailed description of Cryselle, an oral contraceptive containing norgestrel and ethinyl estradiol tablets. It provides information on the composition of the tablets, dosages, storage instructions, and manufacturer details. It also includes details on the packaging, usage directions, prescription schedule, and precautions. Cryselle is intended to prevent pregnancy and should be stored between 20°C to 25°C. The package insert gives comprehensive prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.